Raloxifene and Bevacizumab for severe complications of hereditary haemorrhagic telangiectasia in a haemodialysis patient

Author： Morales Enrique   Morales Rafael   Gutiérrez Eduardo   Rojas-Rivera Jorge   Praga Manuel  

Publisher： Oxford University Press

ISSN： 2048-8505

Source： Clinical Kidney Journal, Vol.5, Iss.6, 2012-12, pp. : 608-609

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Review on Clinical Management and Pharmacological Therapy on Hereditary Haemorrhagic Telangiectasia (HHT)

By  

Current Vascular Pharmacology, Vol. 8, Iss. 4, 2010-07 ,pp. : 473-481

Bentham Science Publishers

Access to resources Recommend Favorite

Argatroban caused severe hypercholesterolaemia in a chronic haemodialysis patient with heparin-induced thrombocytopenia: an unreported adverse effect

By Nakagawa Tetsuya  

NDT PLUS, Vol. 1, Iss. 4, 2008-08 ,pp. : 277-277

Oxford University Press

Access to resources Recommend Favorite

Laparoscopic observations of the liver in hereditary hemorrhagic telangiectasia

By Blonski Wojciech   Regev Arie   Reddy K. Rajender  

Scandinavian Journal of Gastroenterology, Vol. 42, Iss. 12, 2007-01 ,pp. : 1512-1513

Informa Healthcare

Access to resources Recommend Favorite

Gastrointestinal and Hepatic Manifestations of Hereditary Hemorrhagic Telangiectasia

By  

Digestive Diseases, Vol. 16, Iss. 3, 1998-05 ,pp. : 169-174

Karger

Access to resources Recommend Favorite

Hereditary Hemorrhagic Telangiectasia Response to Aminocaproic Acid Treatment - Treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid

By Annichino-Bizzacchi J.M.   Facchini R.M.   Torresan M.Z.   Arruda V.R.  

Thrombosis Research, Vol. 96, Iss. 1, 1999-10 ,pp. : 73-76

Elsevier

Access to resources Recommend Favorite